Divestment27 Aug 2026, 07:21 pm
Metropolis Healthcare Divests EQAS Business for ₹1.25 Cr Equity
AI Summary
Metropolis Healthcare Ltd has transferred its External Quality Assessment Services Business Division (EQAS Division) to its subsidiary, Metropolis Quality Solutions Private Limited (MQSPL), effective August 27, 2026. The transaction was conducted on a slump sale basis for a consideration of INR 1.25 crore, discharged through the issuance of MQSPL equity shares to Metropolis Healthcare. Following the transfer, MQSPL is now responsible for the operations of the EQAS Division. This move is part of the company's strategic restructuring and aligns with the terms of the Business Transfer Agreement (BTA).
Key Highlights
- EQAS Division transferred to subsidiary MQSPL.
- Transaction valued at ₹1.25 crore via equity issuance.
- Effective date of transfer is August 27, 2026.
- Operations now carried out by the subsidiary MQSPL.
Price Impact
More from METROPOLIS